Johnson & Johnson (JNJ) Social Stream
JOHNSON & JOHNSON (JNJ) Price Targets From Analysts
Use the tables below to see what analysts covering JOHNSON & JOHNSON think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-21 | 10 | $215 | $175 | $191.111 | $161.15 | 18.59% |
| 2021-12-15 | 10 | $215 | $175 | $190.555 | $161.15 | 18.25% |
| 2022-01-26 | 9 | $215 | $175 | $189.222 | $161.15 | 17.42% |
| 2022-01-27 | 9 | $215 | $175 | $190 | $161.15 | 17.9% |
| 2022-03-07 | 11 | $215 | $175 | $189.444 | $161.15 | 17.56% |
| 2022-04-04 | 11 | $215 | $175 | $188.8 | $161.15 | 17.16% |
| 2022-04-14 | 11 | $215 | $173 | $188.6 | $161.15 | 17.03% |
| 2022-04-20 | 11 | $215 | $173 | $189.6 | $161.15 | 17.65% |
| 2022-04-21 | 11 | $215 | $173 | $191.2 | $161.15 | 18.65% |
| 2022-05-20 | 12 | $215 | $173 | $190.272 | $161.15 | 18.07% |
| 2022-06-06 | 13 | $215 | $173 | $189.818 | $161.15 | 17.79% |
| 2022-09-07 | 16 | $215 | $165 | $186.333 | $161.15 | 15.63% |
| 2022-09-17 | 16 | $215 | $165 | $186.266 | $161.15 | 15.59% |
| 2022-10-05 | 15 | $215 | $165 | $186.066 | $161.15 | 15.46% |
| 2022-10-12 | 16 | $215 | $165 | $186.066 | $161.15 | 15.46% |
| 2022-10-13 | 16 | $215 | $165 | $186.133 | $161.15 | 15.5% |
| 2022-10-14 | 16 | $215 | $165 | $185.666 | $161.15 | 15.21% |
| 2022-10-19 | 17 | $215 | $165 | $185.4 | $161.15 | 15.05% |
| 2022-10-20 | 17 | $215 | $160 | $184 | $161.15 | 14.18% |
| 2022-11-28 | 16 | $215 | $160 | $184.437 | $161.15 | 14.45% |
| 2022-12-01 | 16 | $215 | $160 | $185.6 | $161.15 | 15.17% |
| 2022-12-12 | 17 | $215 | $160 | $185.466 | $161.15 | 15.09% |
| 2023-01-20 | 17 | $215 | $160 | $185.687 | $161.15 | 15.23% |
| 2023-01-25 | 17 | $215 | $160 | $185.187 | $161.15 | 14.92% |
| 2023-02-21 | 17 | $215 | $168 | $185.937 | $161.15 | 15.38% |
| 2023-03-01 | 18 | $215 | $161 | $184.47 | $161.15 | 14.47% |
| 2023-03-31 | 18 | $215 | $161 | $183.588 | $161.15 | 13.92% |
| 2023-04-11 | 18 | $215 | $161 | $183.529 | $161.15 | 13.89% |
| 2023-04-12 | 18 | $215 | $161 | $183.687 | $161.15 | 13.99% |
| 2023-04-19 | 17 | $215 | $161 | $183.687 | $161.15 | 13.99% |
| 2023-04-21 | 17 | $215 | $161 | $183.312 | $161.15 | 13.75% |
| 2023-06-06 | 17 | $215 | $161 | $182.062 | $161.15 | 12.98% |
| 2023-06-14 | 18 | $215 | $161 | $182.062 | $161.15 | 12.98% |
| 2023-07-11 | 17 | $215 | $161 | $182.2 | $161.15 | 13.06% |
| 2023-07-13 | 17 | $215 | $161 | $181.571 | $161.15 | 12.67% |
| 2023-07-18 | 16 | $215 | $161 | $181.571 | $161.15 | 12.67% |
| 2023-07-21 | 16 | $215 | $161 | $182.461 | $161.15 | 13.22% |
| 2023-07-31 | 15 | $215 | $161 | $183.384 | $161.15 | 13.8% |
| 2023-08-30 | 15 | $215 | $161 | $183.615 | $161.15 | 13.94% |
| 2023-08-31 | 16 | $215 | $161 | $182.357 | $161.15 | 13.16% |
| 2023-09-06 | 16 | $215 | $161 | $181.533 | $161.15 | 12.65% |
| 2023-09-08 | 16 | $215 | $158 | $180.4 | $161.15 | 11.95% |
| 2023-09-12 | 17 | $215 | $158 | $179.687 | $161.15 | 11.5% |
| 2023-10-05 | 18 | $215 | $158 | $179.588 | $161.15 | 11.44% |
| 2023-10-10 | 18 | $215 | $158 | $179.294 | $161.15 | 11.26% |
| 2023-10-13 | 18 | $215 | $158 | $179.411 | $161.15 | 11.33% |
| 2023-10-18 | 18 | $215 | $161 | $179.647 | $161.15 | 11.48% |
| 2023-10-19 | 18 | $215 | $161 | $178.764 | $161.15 | 10.93% |
| 2023-11-10 | 18 | $215 | $155 | $177.882 | $161.15 | 10.38% |
| 2023-12-05 | 18 | $215 | $155 | $177.411 | $161.15 | 10.09% |
| 2023-12-06 | 18 | $215 | $160 | $177.882 | $161.15 | 10.38% |
| 2023-12-13 | 18 | $195 | $160 | $175.062 | $161.15 | 8.63% |
The Trend in the Analyst Price Target
Over the past 12 months, JNJ's average price target has gone down $10.22.
Over the past 47 weeks, JNJ's average upside potential has been 13.27%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-20 | 17 | 215 | 160 | 185.687 | 168.74 | 10.04% |
| 2023-02-21 | 17 | 215 | 168 | 185.937 | 158.00 | 17.68% |
| 2023-06-14 | 18 | 215 | 161 | 182.062 | 161.56 | 12.69% |
| 2023-07-11 | 17 | 215 | 161 | 182.200 | 158.63 | 14.86% |
| 2023-12-13 | 18 | 195 | 160 | 175.250 | 155.79 | 12.49% |
JNJ Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.22 | 6 | 2 | 10 | 0 | 0 | 18 |
The Trend in the Broker Recommendations
JNJ's average broker recommendation rating worsened by 0.12 over the prior 17 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how JOHNSON & JOHNSON fares relative to all US stocks, note that its average analyst price target is higher than 6045.26% of that group.
- JOHNSON & JOHNSON's number of analysts covering the stock is higher than 5997.45% of Pharmaceutical Products stocks.
- In terms of how JOHNSON & JOHNSON fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -877.53% of that group.
- In the context of Pharmaceutical Products stocks, JOHNSON & JOHNSON's upside potential (average analyst target price relative to current price) is greater than 1440.04% of them.
In the Pharmaceutical Products industry, PFE, LLY, and ABT are the three stocks most similar to JOHNSON & JOHNSON regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is JNJ a Buy, Hold or Sell? See the POWR Ratings now!